Payer Decision-Making for Next Generation Sequencing-Based Genetic Tests: Insights from cell-free DNA prenatal genetic screening

PURPOSE: Cell-free DNA (cfDNA) prenatal screening tests have been rapidly adopted into clinical practice, in part due to positive insurance coverage. We evaluated the framework payers used in making coverage decisions to describe a process that should be informative for other sequencing tests. METHO...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Genet Med
Autores principales: Dervan, Andrew P., Deverka, Patricia A., Trosman, Julia R., Weldon, Christine B., Douglas, Michael P., Phillips, Kathryn A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362360/
https://ncbi.nlm.nih.gov/pubmed/27657682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2016.145
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares